ゾルベトゥキシマブによるクラウジン-18. 2の標的化:SPOTLIGHTの結果の見通し
Hanneke W M van Laarhoven1, Sarah Derks2
1Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam 1105AZ, Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, Netherlands.
Lancet (London, England)
|April 17, 2023
まとめ
No abstract available in PubMed .


